À retenir
A scoping review of 2385 records found only 19 studies that used wearables with AI for real-time detection or prediction of cardiovascular events, and most relied on public datasets rather than real-world validation. It maps what exists and does not measure how well any of these systems work.
Study design
Revue des preuves
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Cardiovascular disease causes 18 million deaths a year, and wearables could watch heart signals continuously, but the data are huge and change quickly, which calls for AI that works in real time. The authors set out to identify the main challenges and possible solutions, and how the AI is built and deployed.
Population et méthode
Scoping review. Searches of MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Web of Science Core Collection, IEEE Xplore and the ACM Digital Library gave 2385 unique records. Studies were included if they used wearable devices to collect participant data and applied AI algorithms for real-time analysis to detect or predict cardiovascular events and diseases. After title and abstract screening, 153 papers remained, and after full-text review, 19 studies were included. The abstract does not describe how study quality was rated.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Research on real-time cardiovascular monitoring with AI and wearables is limited and lacks comprehensive validation.
- 2Most of the 19 studies used publicly available wearable datasets instead of testing in real-world settings with recruited participants.
- 3Studies that ran AI in real time often did not report operational characteristics and challenges.
- 4Electrocardiography-based wearable sensors were used most, mainly in hospitals. Methods ranged from traditional machine learning to lightweight deep learning, running on the device or in the cloud.
Limites et incertitude
- 1With only 19 included studies, which varied widely in devices and AI methods, the review cannot say which approach is best.
- 2The abstract gives no accuracy figures, so it cannot show how well real-time AI detects cardiovascular events.
- 3Scoping reviews map the evidence and do not rate its quality or combine results statistically.
- 4The included studies leaned on public datasets and hospital settings, so they say little about everyday use. This reading rests on the abstract only.
Mise en perspective
Claims that a wearable and AI can spot heart problems in real time are far ahead of the evidence for everyday community use. Treat alerts as a prompt to check in with a clinician, not as a diagnosis, and do not rely on them in an emergency. Symptoms such as chest pain need urgent care whatever a device shows.
Vos données
Resting heart rate, activity and any ECG or rhythm features your watch offers are the data this field builds on. Use the same device, wear it consistently and look at trends, and share any repeated alerts with your clinician.
Comprendre ce type de preuve
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Cardiovascular diseases remain the leading cause of mortality worldwide, accounting for 18 million deaths annually. Detection and prediction of cardiovascular conditions are essential for timely intervention and improved patient outcomes. Wearable devices offer a promising, noninvasive solution for continuous monitoring of cardiovascular signals, vital signs, and physical activity. However, the large data volumes generated by these devices and the rapid fluctuations in cardiovascular signals necessitate advanced artificial intelligence (AI) techniques for real-time analysis and effective clinical decision-making.
Objective
The objective of this scoping review was to identify the main challenges of AI-driven platforms for real-time cardiovascular condition monitoring with wearable devices and explore potential solutions. In addition, this review aimed to examine how AI algorithms are developed for robust monitoring and how deployment pipelines are optimized to enable real-time cardiovascular condition monitoring.
Methods
A comprehensive search was conducted in the following electronic databases: MEDLINE(R) ALL (Ovid), Embase (Ovid), Cochrane Central Register of Controlled Trials (Ovid), Web of Science Core Collection (Clarivate), IEEE Xplore, and ACM Digital Library, yielding 2385 unique records. Inclusion criteria focused on studies that used wearable devices for participant data collection and applied AI algorithms for real-time analysis to detect or predict cardiovascular events and diseases. After title and abstract screening, 153 papers remained, and following a full-text review, 19 studies met the inclusion criteria.
Results
The findings indicate that despite the promise of AI and wearable devices, research on real-time cardiovascular monitoring remains limited and lacks comprehensive validation. Most studies relied on publicly available wearable datasets rather than real-world validation with recruited participants in community settings. Studies that deployed AI algorithms in real time frequently failed to report operational characteristics and challenges. Electrocardiography-based wearable sensors were the most frequently used devices, primarily in hospital settings. A variety of AI techniques, ranging from traditional machine learning to lightweight deep learning algorithms, were deployed either on wearable devices or via cloud-based processing.
Conclusions
Robust, interdisciplinary research is needed to harness the full potential of AI-driven, real-time cardiovascular health management using wearable devices. This includes the development and validation of scalable solutions for continuous community-based deployment. Furthermore, real-world challenges such as participant compliance, hardware and connectivity constraints, and AI model optimization for real-time continuous monitoring must be carefully addressed.
Sources et attribution
AI-Driven Real-Time Monitoring of Cardiovascular Conditions With Wearable Devices: Scoping Review.
Abedi A, Verma A, Jain D, Kaetheeswaran J, Chui C, Lankarany M, Khan SS.
JMIR mHealth and uHealth · 2025-11-11
DOI: 10.2196/73846 ↗PubMed · 41218203 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

